BioCentury
ARTICLE | Clinical News

Verigene C regulatory update

December 17, 2012 8:00 AM UTC

Nanosphere said FDA granted 510(k) clearance for its Verigene C. difficile Test. The in vitro diagnostic detects the toxin A and B gene sequences of Clostridium difficile and identifies the BI/NAP1/02...